Eppix Labs
5 of 6 fields documentedReview recommendedCJC-1295 No DAC (10 mg)
Exact name catalog match · No active affiliate relationship · Price badge is not an overall recommendation
Listed price
$40.00
$4.00 per mg
In stock
Supplier comparison
The CJC-1295 name is used for materially different catalog products. A useful comparison must separate DAC and no-DAC listings before evaluating price or documentation. This comparison is for laboratory research and is not a product recommendation.
Compare exact listings ↓What matters for CJC-1295
1. Confirm the material
Determine whether the material includes the drug-affinity-complex modification or is a no-DAC modified GHRH product. Those records should not be merged.
2. Compare the same quantity
Compare price per mg only within the same documented molecular form and vial size context.
3. Connect the evidence
Require the sequence, modification status, expected mass, lot and identity result to agree across the listing and report.
Each price is tied to a specific vial size. Price per mg is calculated from the amount printed on the listing.
A general report library is distinguished from documentation connected to the exact product and current offered lot.
The lowest price is not treated as the strongest documentation, best supplier, or evidence of product identity or suitability.
For laboratory research only
Listings now default to lowest tracked price per mg. The highlighted price badge is a catalog-price signal only, not a quality, safety, or documentation ranking.
The document count covers six basic checks. “Not found” means we could not confirm it from the public records we reviewed—not that the testing never happened.
Affiliate disclosure: Some links may earn PDD a commission. Affiliate status does not change what we report or how suppliers are ordered.
Eppix Labs
5 of 6 fields documentedReview recommendedCJC-1295 No DAC (10 mg)
Exact name catalog match · No active affiliate relationship · Price badge is not an overall recommendation
Listed price
$40.00
$4.00 per mg
In stock
Transition Biotech
6 of 6 fields documentedChecked 13 days agoCJC-1295 No DAC (10 mg)
Exact name catalog match · No active affiliate relationship
Listed price
$54.99
$5.50 per mg
In stock
PS Peptides
5 of 6 fields documentedPossibly outdatedCJC-1295 No DAC (10 mg)
Exact name catalog match · Affiliate relationship
Listed price
$59.99
$6.00 per mg
Est. with PDD10: $53.99
$5.40/mg
In stock
PS Peptides
5 of 6 fields documentedPossibly outdatedCJC-1295 No DAC (5 mg)
Exact name catalog match · Affiliate relationship
Listed price
$35.99
$7.20 per mg
Est. with PDD10: $32.39
$6.48/mg
In stock
Ameano Peptides
1 of 6 fields documentedPossibly outdatedCJC-1295 No DAC (5 mg)
Exact name catalog match · No active affiliate relationship
Listed price
$38.00
$7.60 per mg
In stock
PDD price and documentation watch
Join the weekly Research Brief. When PDD records a meaningful CJC-1295 price, availability, COA or supplier-documentation change, we’ll include it in an upcoming update.
One weekly email. Not every tracked peptide changes every week. Unsubscribe at any time.
Send me the weekly PDD watch
Includes CJC-1295 whenever a material tracked change is recorded.
By subscribing, you agree to receive PDD research emails. Unsubscribe at any time.
Already subscribed? Get your free checklist.
How to use this page
First confirm that the listing names the intended molecule, form and vial quantity. Then inspect whether the available analytical record connects the product, lot, laboratory, method and result.
Public discount estimates are shown only when PDD has a documented percentage. Shipping, tax, minimum-order conditions and later catalog changes can alter the final cost.
Before procurement, verify the live listing and request current-lot records when the public evidence does not establish that connection.
Evidence boundary
Documentation coverage describes what PDD located in public records. It is not proof of safety, efficacy, authenticity, sterility, regulatory compliance or suitability. Affiliate compensation does not change inclusion, evidence states or default ordering.
No. They differ in molecular design and should be treated as separate materials for both evidence and pricing comparisons.
The label may reveal whether DAC status and vial strength are specified or left ambiguous.
The report should identify the exact sequence and modification status rather than using CJC-1295 as a generic umbrella term.